Clinical Trial Update: Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating prophylactic preoperative HIPEC to reduce peritoneal recurrence in advanced gastric cancer at high risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• HIPEC

Snippet

Sponsor: Jagiellonian University | Conditions: Gastric Cancer | Phase 3 | Status: RECRUITING